ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

VNDA Vanda Pharmaceuticals Inc

5.09
0.17 (3.46%)
31 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Vanda Pharmaceuticals Inc NASDAQ:VNDA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.17 3.46% 5.09 4.96 5.14 5.04 4.88 4.95 446,052 01:00:00

Vanda Pharmaceuticals to Announce Third Quarter 2016 Financial Results on November 2, 2016

12/10/2016 9:30pm

PR Newswire (US)


Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Vanda Pharmaceuticals Charts.

WASHINGTON, Oct. 12, 2016 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced it will release results for the third quarter of 2016 on Wednesday, November 2, 2016, after the market closes.

Vanda will host a conference call at 4:30 PM ET on Wednesday, November 2, 2016, during which management will discuss the third quarter 2016 financial results and other corporate activities. To participate in the conference call, please dial 1-888-771-4371 (domestic) or 1-847-585-4405 (international) and use passcode 43560411.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com.  Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, November 2, 2016, beginning at 7:00 PM ET and will be accessible until Wednesday, November 9, 2016, at 11:59 PM ET.  The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers.  The passcode number is 43560411.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.  For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Senior Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-third-quarter-2016-financial-results-on-november-2-2016-300343397.html

SOURCE Vanda Pharmaceuticals Inc.

Copyright 2016 PR Newswire

1 Year Vanda Pharmaceuticals Chart

1 Year Vanda Pharmaceuticals Chart

1 Month Vanda Pharmaceuticals Chart

1 Month Vanda Pharmaceuticals Chart